TG Therapeutics, Inc. (TGTX)

NASDAQ: TGTX · Real-Time Price · USD

43.44

-1.93 (-4.25%)

May 2, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Financial numbers in millions USD.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Novel Treatments for B-cell Diseases	329	Log In	Log In	Log In	Log In	Upgrade
Novel Treatments for B-cell Diseases Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financial numbers in millions USD.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United States	329	Log In	Log In	Log In	Log In	Upgrade
United States Growth	40.80%	Log In	Log In	Log In	Log In	Upgrade